| First Author | Taylor S | Year | 2018 |
| Journal | J Neurosci | Volume | 38 |
| Issue | 40 | Pages | 8707-8722 |
| PubMed ID | 30201775 | Mgi Jnum | J:265921 |
| Mgi Id | MGI:6201688 | Doi | 10.1523/JNEUROSCI.0734-18.2018 |
| Citation | Taylor S, et al. (2018) Suppressing Interferon-gamma Stimulates Microglial Responses and Repair of Microbleeds in the Diabetic Brain. J Neurosci 38(40):8707-8722 |
| abstractText | Microcirculatory damage is a common complication for those with vascular risk factors, such as diabetes. To resolve vascular insults, the brain's immune cells (microglia) must rapidly envelop the site of injury. Currently, it is unknown whether Type 1 diabetes, a condition associated with chronic immune system dysfunction, alters microglial responses to damage and what mechanisms are responsible. Using in vivo two-photon microscopy in adult male mice, we show that microglial envelopment of laser-induced cerebral microbleeds is diminished in a hyperglycemic mouse model of Type 1 diabetes, which could not be fully rescued with chronic insulin treatment. Microglia were important for vessel repair because reduced microglial accumulation in diabetic mice or near-complete depletion in healthy controls was associated with greater secondary leakage of the damaged vessel. Broadly suppressing inflammation with dexamethasone in diabetic mice but not healthy controls, significantly enhanced microglial responses to microbleeds and attenuated secondary vessel leakage. These enhancements were associated with changes in IFN-gamma signaling because dexamethasone suppressed abnormally high levels of IFN-gamma protein levels in brain and blood serum of diabetic mice. Further, blocking IFN-gamma in diabetic mice with neutralizing antibodies restored normal microglial chemotaxic responses and purinoceptor P2ry12 gene expression, as well as mitigated secondary leakage. These results suggest that abnormal IFN-gamma signaling disrupts microglial function in the diabetic brain, and that immunotherapies targeting IFN-gamma can stimulate microglial repair of damaged vessels.SIGNIFICANCE STATEMENT Although Type 1 diabetes is an established risk factor for vascular complications, such as microbleeds, and is known to hinder wound healing in the body, no study has examined how diabetes impacts the brain's innate immune reparative response (involving cells called microglia) to vascular injury. Here we show that microglial responses to brain microbleeds were diminished in diabetic animals, which also exacerbated secondary leakage from damaged vessels. These impairments were related to abnormally high levels of the proinflammatory cytokine IFN-gamma because reducing IFN-gamma with immunosuppressant drugs or blocking antibodies helped restore normal microglial responses and repair of damaged vessels. These data highlight the use of IFN-gamma modulating therapeutics to enhance vascular repair in at-risk populations. |
